Point-of-care ultrasonography in the initial characterization of patients with COVID-19.

BACKGROUND

There is growing evidence regarding the imaging findings of coronavirus disease 2019 (COVID-19) in chest X-rays and computed tomography scans; however, their availability during this pandemic outbreak might be compromised. Currently, the role of point-of-care ultrasonography (POCUS) has yet to be explored.

OBJECTIVES

To describe the POCUS findings of COVID-19 in patients with the disease admitted to the emergency department (ED), correlating them with vital signs, laboratory and radiologic results, therapeutic decisions, and the prognosis.

METHODS

Prospective study performed in the ED of 2 academic hospitals. Patients with highly suspected or confirmed COVID-19 underwent a lung ultrasonography (lung POCUS), focused cardiac ultrasound (FOCUS), and inferior vena cava (IVC) exam.

RESULTS

Between March and April 2020, 96 patients were enrolled. The mean age was 68.2 years (SD 17.5). The most common findings in the lung POCUS were an irregular pleural line (63.2%), bilateral confluence (55.2%), and isolated B-lines (53.1%), which were associated with a positive RT-PCR (odds ratio 4.327; 95% CI 1.216-15.401;  < .001), and correlated with IL-6 levels (rho = 0.622;  = .002). The IVC negatively correlated with levels of expiratory pO (rho = -0.539;  = .014) and inspiratory pO (rho = -0.527;  = 0.017), and expiratory diameter positively correlated with troponin I (rho = 0.509;  = .03). After the POCUS exam, almost 20% of the patients had an associated condition that required a change in their treatment or management.

CONCLUSIONS

POCUS parameters have the potential to impact the diagnosis, management, and prognosis of patients with confirmed or suspected COVID-19.